ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Other Receivables
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Other Receivables of $789.09 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2015-12-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2015-12-14
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other receivables for the quarter ending 2015-09-30 was $168.69K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other receivables for the quarter ending 2015-06-30 was $340.89K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other receivables for the quarter ending 2015-03-31 was $269.99K, a 54.97% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other receivables for the quarter ending 2014-12-31 was $9.51K, a 19.61% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other receivables for fiscal 2015 was $789.09K, a 2950.57% increase from fiscal 2014.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other receivables for fiscal 2014 was $25.87K.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other receivables for fiscal 2013 was -$1.08K, a 100.12% decline from fiscal 2012.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other receivables for fiscal 2012 was $938.18K, a 27.43% increase from fiscal 2011.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month | Increase (Decrease) in Other Receivables 98 month | Increase (Decrease) in Other Receivables 101 month | Increase (Decrease) in Other Receivables 104 month | Increase (Decrease) in Other Receivables 107 month | Increase (Decrease) in Other Receivables 110 month | Increase (Decrease) in Other Receivables 113 month | Increase (Decrease) in Other Receivables 116 month | Increase (Decrease) in Other Receivables 119 month | Increase (Decrease) in Other Receivables 122 month | Increase (Decrease) in Other Receivables 125 month | Increase (Decrease) in Other Receivables 128 month | Increase (Decrease) in Other Receivables 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-09-30 | $168.69K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | $509.59K derived: sum of 2 quarters · filed 2015-12-14 | $779.58K derived: sum of 3 quarters · filed 2015-12-14 | $789.09K 10-K · filed 2015-12-14 | ||||||||||||
| 2015-06-30 | $340.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $610.89K derived: sum of 2 quarters · filed 2015-08-04 | $620.39K 10-Q · filed 2015-08-04 | $128.28K derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||
| 2015-03-31 | $269.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | $279.50K 10-Q · filed 2015-05-11 | -$212.62K derived: sum of 3 quarters · filed 2015-12-14 | -$305.99K derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||
| 2014-12-31 | $9.51K 10-Q · filed 2015-02-09 | -$482.61K derived: sum of 2 quarters · filed 2015-12-14 | -$575.99K derived: sum of 3 quarters · filed 2015-12-14 | $23.55K derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||
| 2014-09-30 | -$492.12K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | -$585.49K derived: sum of 2 quarters · filed 2015-12-14 | $14.04K derived: sum of 3 quarters · filed 2015-12-14 | $25.87K 10-K · filed 2015-12-14 | ||||||||||||
| 2014-06-30 | -$93.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $506.16K derived: sum of 2 quarters · filed 2015-08-04 | $517.99K 10-Q · filed 2015-08-04 | $517.99K derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||
| 2014-03-31 | $599.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | $611.36K 10-Q · filed 2015-05-11 | $611.36K derived: sum of 3 quarters · filed 2015-12-14 | $611.36K derived: sum of 4 quarters · filed 2015-12-14 | $3.15M 10-Q · filed 2014-05-06 | |||||||||||
| 2013-12-31 | $11.82K 10-Q · filed 2014-02-04 | $11.82K derived: sum of 2 quarters · filed 2015-12-14 | $11.82K derived: sum of 3 quarters · filed 2015-12-14 | $2.55M 10-Q · filed 2014-02-04 | ||||||||||||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | $0.00 derived: sum of 2 quarters · filed 2015-12-14 | -$1.08K 10-K · filed 2015-12-14 | $2.54M 10-K · filed 2013-12-18 | ||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | -$1.08K 10-Q · filed 2014-08-12 | $2.54M 10-Q · filed 2013-08-07 | |||||||||||||
| 2013-03-31 | -$1.08K 10-Q · filed 2014-05-06 | $2.54M 10-Q · filed 2013-05-09 | ||||||||||||||
| 2012-12-31 | $2.54M 10-Q · filed 2013-02-13 | |||||||||||||||
| 2012-09-30 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $239.96K derived: sum of 2 quarters · filed 2014-11-25 | $518.94K derived: sum of 3 quarters · filed 2014-11-25 | $938.18K 10-K · filed 2014-11-25 | $2.54M 10-K · filed 2012-12-28 | |||||||||||
| 2012-06-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07 | -$1.59M derived: sum of 2 quarters · filed 2013-08-07 | -$1.17M 10-Q · filed 2013-08-07 | -$915.04K derived: sum of 4 quarters · filed 2013-08-07 | $431.44K 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | $278.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | $698.22K 10-Q · filed 2013-05-09 | $956.71K derived: sum of 3 quarters · filed 2013-05-09 | $1.04M derived: sum of 4 quarters · filed 2013-05-09 | $2.30M 10-Q · filed 2012-05-08 | |||||||||||
| 2011-12-31 | $419.24K 10-Q · filed 2013-02-13 | $677.72K derived: sum of 2 quarters · filed 2013-02-13 | $759.93K derived: sum of 3 quarters · filed 2013-02-13 | $1.24M derived: sum of 4 quarters · filed 2013-02-13 | $2.02M 10-Q · filed 2012-02-09 | |||||||||||
| 2011-09-30 | $258.48K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | $340.69K derived: sum of 2 quarters · filed 2012-12-28 | $822.67K derived: sum of 3 quarters · filed 2012-12-28 | $736.25K 10-K · filed 2012-12-28 | $1.60M 10-Q · filed 2012-08-13 | |||||||||||
| 2011-06-30 | $82.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-13 | $564.19K derived: sum of 2 quarters · filed 2012-08-13 | $477.77K 10-Q · filed 2012-08-13 | $621.09K derived: sum of 4 quarters · filed 2012-08-13 | $1.35M 10-Q · filed 2011-08-08 | |||||||||||
| 2011-03-31 | $481.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-08 | $395.56K 10-Q · filed 2012-05-08 | $538.88K derived: sum of 3 quarters · filed 2012-05-08 | |||||||||||||
| 2010-12-31 | -$86.42K 10-Q · filed 2012-02-09 | $56.90K derived: sum of 2 quarters · filed 2012-02-09 | ||||||||||||||
| 2010-09-30 | $143.32K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $872.13K 10-K · filed 2011-12-20 | ||||||||||||||
| 2010-06-30 | $728.81K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |